Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 86

1.

Frontal haemodynamic responses in depression and the effect of electroconvulsive therapy.

Downey D, Brigadoi S, Trevithick L, Elliott R, Elwell C, McAllister-Williams RH, Anderson IM.

J Psychopharmacol. 2019 Aug;33(8):1003-1014. doi: 10.1177/0269881119858313. Epub 2019 Jun 25.

2.

Bipolar and psychotic disorders in elite athletes: a narrative review.

Currie A, Gorczynski P, Rice SM, Purcell R, McAllister-Williams RH, Hitchcock ME, Hainline B, Reardon CL.

Br J Sports Med. 2019 Jun;53(12):746-753. doi: 10.1136/bjsports-2019-100685. Epub 2019 May 16. Review.

PMID:
31097458
3.

Associations between childhood maltreatment and inflammatory markers.

Palmos AB, Watson S, Hughes T, Finkelmeyer A, McAllister-Williams RH, Ferrier N, Anderson IM, Nair R, Young AH, Strawbridge R, Cleare AJ, Chung R, Frissa S, Goodwin L, Hotopf M, Hatch SL, Wang H, Collier DA, Thuret S, Breen G, Powell TR.

BJPsych Open. 2019 Jan;5(1):e3. doi: 10.1192/bjo.2018.80.

4.

The association between sleep and cognitive abnormalities in bipolar disorder.

Bradley AJ, Anderson KN, Gallagher P, McAllister-Williams RH.

Psychol Med. 2019 Jan 16:1-8. doi: 10.1017/S0033291718004038. [Epub ahead of print]

PMID:
30646966
5.

Guidelines on prescribing psychotropic medication during the perinatal period.

Romaine E, McAllister-Williams RH.

Br J Hosp Med (Lond). 2019 Jan 2;80(1):27-32. doi: 10.12968/hmed.2019.80.1.27.

PMID:
30592677
6.

Medication nonadherence in bipolar disorder: a narrative review.

Jawad I, Watson S, Haddad PM, Talbot PS, McAllister-Williams RH.

Ther Adv Psychopharmacol. 2018 Oct 16;8(12):349-363. doi: 10.1177/2045125318804364. eCollection 2018 Dec. Review.

7.

Treatment-resistant and multi-therapy-resistant criteria for bipolar depression: consensus definition.

Hidalgo-Mazzei D, Berk M, Cipriani A, Cleare AJ, Florio AD, Dietch D, Geddes JR, Goodwin GM, Grunze H, Hayes JF, Jones I, Kasper S, Macritchie K, McAllister-Williams RH, Morriss R, Nayrouz S, Pappa S, Soares JC, Smith DJ, Suppes T, Talbot P, Vieta E, Watson S, Yatham LN, Young AH, Stokes PRA.

Br J Psychiatry. 2019 Jan;214(1):27-35. doi: 10.1192/bjp.2018.257. Epub 2018 Dec 6. Erratum in: Br J Psychiatry. 2019 May;214(5):309.

PMID:
30520709
8.

Multiple-therapy-resistant major depressive disorder: a clinically important concept.

McAllister-Williams RH, Christmas DMB, Cleare AJ, Currie A, Gledhill J, Insole L, Malizia AL, McGeever M, Morriss R, Robinson LJ, Scott M, Stokes PRA, Talbot PS, Young AH.

Br J Psychiatry. 2018 May;212(5):274-278. doi: 10.1192/bjp.2017.33.

PMID:
30517072
9.

Study protocol for a randomised pragmatic trial comparing the clinical and cost effectiveness of lithium and quetiapine augmentation in treatment resistant depression (the LQD study).

Marwood L, Taylor R, Goldsmith K, Romeo R, Holland R, Pickles A, Hutchinson J, Dietch D, Cipriani A, Nair R, Attenburrow MJ, Young AH, Geddes J, McAllister-Williams RH, Cleare AJ.

BMC Psychiatry. 2017 Jun 26;17(1):231. doi: 10.1186/s12888-017-1393-0.

10.

A Real-world What-Where-When Memory Test.

Smulders TV, Black-Dominique A, Choudhury TS, Constantinescu SE, Foka K, Walker TJ, Dick K, Bradwel S, McAllister-Williams RH, Gallagher P.

J Vis Exp. 2017 May 16;(123). doi: 10.3791/55646.

11.

Erratum to "Analysing UK clinicians' understanding of cognitive symptoms in major depression: A survey of primary care physicians and psychiatrists" [J. Affect. Disord. 207 (2017) 346-352].

McAllister-Williams RH, Bones K, Goodwin GM, Harrison J, Katona C, Rasmussen J, Strong S, Young AH.

J Affect Disord. 2017 Aug 1;217:306-307. doi: 10.1016/j.jad.2017.04.023. Epub 2017 Apr 26. No abstract available.

PMID:
28456050
12.

British Association for Psychopharmacology consensus guidance on the use of psychotropic medication preconception, in pregnancy and postpartum 2017.

McAllister-Williams RH, Baldwin DS, Cantwell R, Easter A, Gilvarry E, Glover V, Green L, Gregoire A, Howard LM, Jones I, Khalifeh H, Lingford-Hughes A, McDonald E, Micali N, Pariante CM, Peters L, Roberts A, Smith NC, Taylor D, Wieck A, Yates LM, Young AH; endorsed by the British Association for Psychopharmacology.

J Psychopharmacol. 2017 May;31(5):519-552. doi: 10.1177/0269881117699361. Epub 2017 Apr 25.

13.

Randomised controlled trial of ketamine augmentation of electroconvulsive therapy to improve neuropsychological and clinical outcomes in depression (Ketamine-ECT study).

Anderson IM, Blamire A, Branton T, Brigadoi S, Clark R, Downey D, Dunn G, Easton A, Elliott R, Elwell C, Hayden K, Holland F, Karim S, Lowe J, Loo C, Nair R, Oakley T, Prakash A, Sharma PK, Williams SR, McAllister-Williams RH.

Southampton (UK): NIHR Journals Library; 2017 Mar.

14.

Ketamine augmentation of electroconvulsive therapy to improve neuropsychological and clinical outcomes in depression (Ketamine-ECT): a multicentre, double-blind, randomised, parallel-group, superiority trial.

Anderson IM, Blamire A, Branton T, Clark R, Downey D, Dunn G, Easton A, Elliott R, Elwell C, Hayden K, Holland F, Karim S, Loo C, Lowe J, Nair R, Oakley T, Prakash A, Sharma PK, Williams SR, McAllister-Williams RH; Ketamine-ECT Study team.

Lancet Psychiatry. 2017 May;4(5):365-377. doi: 10.1016/S2215-0366(17)30077-9. Epub 2017 Mar 27.

15.

Lessons from a pilot and feasibility randomised trial in depression (Blood pressure Rapid Intensive Lowering And Normal Treatment for Mood and cognition in persistent depression (BRILiANT mood study)).

Olsen K, Howel D, Barber R, Ford GA, Gallagher P, McAllister-Williams RH, Nilsson J, O'Brien J, Parker J, Thomas A.

Pilot Feasibility Stud. 2015 Dec 22;1:44. doi: 10.1186/s40814-015-0042-y. eCollection 2015.

16.

Analysing UK clinicians' understanding of cognitive symptoms in major depression: A survey of primary care physicians and psychiatrists.

McAllister-Williams RH, Bones K, Goodwin GM, Harrison J, Katona C, Rasmussen J, Strong S, Young AH.

J Affect Disord. 2017 Jan 1;207:346-352. doi: 10.1016/j.jad.2016.09.036. Epub 2016 Sep 28. Erratum in: J Affect Disord. 2017 Aug 1;217:306-307.

PMID:
27743537
17.

Altered hippocampal function in major depression despite intact structure and resting perfusion.

Finkelmeyer A, Nilsson J, He J, Stevens L, Maller JJ, Moss RA, Small S, Gallagher P, Coventry K, Ferrier IN, McAllister-Williams RH.

Psychol Med. 2016 Jul;46(10):2157-68. doi: 10.1017/S0033291716000702. Epub 2016 May 19.

PMID:
27192934
18.

The interrelationship between attentional and executive deficits in major depressive disorder.

Nilsson J, Thomas AJ, Stevens LH, McAllister-Williams RH, Ferrier IN, Gallagher P.

Acta Psychiatr Scand. 2016 Jul;134(1):73-82. doi: 10.1111/acps.12570. Epub 2016 Apr 1.

PMID:
27037665
19.

Assessment and management of agitation in psychiatry: Expert consensus.

Garriga M, Pacchiarotti I, Kasper S, Zeller SL, Allen MH, Vázquez G, Baldaçara L, San L, McAllister-Williams RH, Fountoulakis KN, Courtet P, Naber D, Chan EW, Fagiolini A, Möller HJ, Grunze H, Llorca PM, Jaffe RL, Yatham LN, Hidalgo-Mazzei D, Passamar M, Messer T, Bernardo M, Vieta E.

World J Biol Psychiatry. 2016;17(2):86-128. doi: 10.3109/15622975.2015.1132007. Review.

PMID:
26912127
20.

Antidepressant augmentation with metyrapone for treatment-resistant depression (the ADD study): a double-blind, randomised, placebo-controlled trial.

McAllister-Williams RH, Anderson IM, Finkelmeyer A, Gallagher P, Grunze HC, Haddad PM, Hughes T, Lloyd AJ, Mamasoula C, McColl E, Pearce S, Siddiqi N, Sinha BN, Steen N, Wainwright J, Winter FH, Ferrier IN, Watson S; ADD Study Team.

Lancet Psychiatry. 2016 Feb;3(2):117-27. doi: 10.1016/S2215-0366(15)00436-8. Epub 2015 Dec 23.

PMID:
26727041
21.

Study protocol for the randomised controlled trial: Ketamine augmentation of ECT to improve outcomes in depression (Ketamine-ECT study).

Trevithick L, McAllister-Williams RH, Blamire A, Branton T, Clark R, Downey D, Dunn G, Easton A, Elliott R, Ellwell C, Hayden K, Holland F, Karim S, Lowe J, Loo C, Nair R, Oakley T, Prakash A, Sharma PK, Williams SR, Anderson IM.

BMC Psychiatry. 2015 Oct 21;15:257. doi: 10.1186/s12888-015-0641-4.

22.

Early life trauma, depression and the glucocorticoid receptor gene--an epigenetic perspective.

Smart C, Strathdee G, Watson S, Murgatroyd C, McAllister-Williams RH.

Psychol Med. 2015 Dec;45(16):3393-410. doi: 10.1017/S0033291715001555. Epub 2015 Sep 21. Review.

PMID:
26387521
23.

Managing inadequate antidepressant response in depressive illness.

Haddad PM, Talbot PS, Anderson IM, McAllister-Williams RH.

Br Med Bull. 2015 Sep;115(1):183-201. doi: 10.1093/bmb/ldv034. Epub 2015 Aug 26. Review.

PMID:
26311502
24.

Test-retest reliability and task order effects of emotional cognitive tests in healthy subjects.

Adams T, Pounder Z, Preston S, Hanson A, Gallagher P, Harmer CJ, McAllister-Williams RH.

Cogn Emot. 2016 Nov;30(7):1247-59. doi: 10.1080/02699931.2015.1055713. Epub 2015 Jul 29.

PMID:
26219310
25.

Randomised controlled trial of Antiglucocorticoid augmentation (metyrapone) of antiDepressants in Depression (ADD Study).

Ferrier IN, Anderson IM, Barnes J, Gallagher P, Grunze HCR, Haddad PM, House AO, Hughes T, Lloyd AJ, Mamasoula C, McColl E, Pearce S, Siddiqi N, Sinha B, Speed C, Steen N, Wainwright J, Watson S, Winter FH, McAllister-Williams RH; the ADD Study Team.

Southampton (UK): NIHR Journals Library; 2015 Jun.

26.

Neurocognitive intra-individual variability in mood disorders: effects on attentional response time distributions.

Gallagher P, Nilsson J, Finkelmeyer A, Goshawk M, Macritchie KA, Lloyd AJ, Thompson JM, Porter RJ, Young AH, Ferrier IN, McAllister-Williams RH, Watson S.

Psychol Med. 2015 Oct;45(14):2985-97. doi: 10.1017/S0033291715000926. Epub 2015 Jun 15.

PMID:
26073667
27.

Evidence-based guidelines for treating depressive disorders with antidepressants: A revision of the 2008 British Association for Psychopharmacology guidelines.

Cleare A, Pariante CM, Young AH, Anderson IM, Christmas D, Cowen PJ, Dickens C, Ferrier IN, Geddes J, Gilbody S, Haddad PM, Katona C, Lewis G, Malizia A, McAllister-Williams RH, Ramchandani P, Scott J, Taylor D, Uher R; Members of the Consensus Meeting.

J Psychopharmacol. 2015 May;29(5):459-525. doi: 10.1177/0269881115581093. Epub 2015 May 12.

PMID:
25969470
28.

Cortisol awakening response and spatial working memory in man: a U-shaped relationship.

Moriarty AS, Bradley AJ, Anderson KN, Watson S, Gallagher P, McAllister-Williams RH.

Hum Psychopharmacol. 2014 May;29(3):295-8. doi: 10.1002/hup.2399. Epub 2014 Mar 27.

PMID:
24911579
29.

Metyrapone in treatment-resistant depression.

Sigalas PD, Garg H, Watson S, McAllister-Williams RH, Ferrier IN.

Ther Adv Psychopharmacol. 2012 Aug;2(4):139-49. doi: 10.1177/2045125312436597.

30.

Study protocol for the randomised controlled trial: antiglucocorticoid augmentation of anti-Depressants in Depression (The ADD Study).

McAllister-Williams RH, Smith E, Anderson IM, Barnes J, Gallagher P, Grunze HC, Haddad PM, House AO, Hughes T, Lloyd AJ, McColl EM, Pearce SH, Siddiqi N, Sinha B, Speed C, Steen IN, Wainright J, Watson S, Winter FH, Ferrier IN.

BMC Psychiatry. 2013 Aug 3;13:205. doi: 10.1186/1471-244X-13-205.

31.

Somatodendritic 5-hydroxytryptamine1A (5-HT1A) autoreceptor function in major depression as assessed using the shift in electroencephalographic frequency spectrum with buspirone.

McAllister-Williams RH, Alhaj HA, Massey A, Pankiv J, Reckermann U.

Psychol Med. 2014 Mar;44(4):767-77. doi: 10.1017/S0033291713001475. Epub 2013 Jul 1.

PMID:
23809646
32.

A naturalistic evaluation and audit database of agomelatine: clinical outcome at 12 weeks.

Sparshatt A, McAllister Williams RH, Baldwin DS, Haddad PM, Bazire S, Weston E, Taylor P, Taylor D.

Acta Psychiatr Scand. 2013 Sep;128(3):203-11. doi: 10.1111/acps.12044. Epub 2012 Dec 14.

PMID:
23240677
33.

Effects of intrinsic and extrinsic motivation on attention and memory.

Robinson LJ, Stevens LH, Threapleton CJ, Vainiute J, McAllister-Williams RH, Gallagher P.

Acta Psychol (Amst). 2012 Oct;141(2):243-9. doi: 10.1016/j.actpsy.2012.05.012. Epub 2012 Jun 26.

PMID:
22738789
34.

Effect of low-dose acute tryptophan depletion on the specificity of autobiographical memory in healthy subjects with a family history of depression.

Alhaj HA, Selman M, Jervis V, Rodgers J, Barton S, McAllister-Williams R.

Psychopharmacology (Berl). 2012 Jul;222(2):285-92. doi: 10.1007/s00213-012-2644-x.

PMID:
22286957
35.

Central glucocorticoid receptor-mediated effects of the antidepressant, citalopram, in humans: a study using EEG and cognitive testing.

Pariante CM, Alhaj HA, Arulnathan VE, Gallagher P, Hanson A, Massey E, McAllister-Williams RH.

Psychoneuroendocrinology. 2012 May;37(5):618-28. doi: 10.1016/j.psyneuen.2011.08.011. Epub 2011 Sep 29.

PMID:
21958534
36.

Serotonin Syndrome following Introduction of Venlafaxine following Withdrawal of Phenelzine: Implications for Drug Washout Periods.

Yates SJ, Ahuja N, Gartside SE, McAllister-Williams RH.

Ther Adv Psychopharmacol. 2011 Aug;1(4):125-7. doi: 10.1177/2045125311413497. No abstract available.

37.

The use of the EEG in measuring therapeutic drug action: focus on depression and antidepressants.

Alhaj H, Wisniewski G, McAllister-Williams RH.

J Psychopharmacol. 2011 Sep;25(9):1175-91. doi: 10.1177/0269881110388323. Epub 2010 Nov 24. Review.

PMID:
21106608
38.

Lithium in bipolar and other affective disorders: prescribing practice in the UK.

Paton C, Barnes TR, Shingleton-Smith A, McAllister-Williams RH, Kirkbride J, Jones PB, McIntyre S; POMH-UK project team.

J Psychopharmacol. 2010 Dec;24(12):1739-46. doi: 10.1177/0269881110367728. Epub 2010 May 20.

PMID:
20488832
39.

Hematological effects of valproate in psychiatric patients: what are the risk factors?

Vasudev K, Keown P, Gibb I, McAllister-Williams RH.

J Clin Psychopharmacol. 2010 Jun;30(3):282-5. doi: 10.1097/JCP.0b013e3181db2684.

PMID:
20473063
40.

The use of antidepressants in clinical practice: focus on agomelatine.

McAllister-Williams RH, Baldwin DS, Haddad PM, Bazire S.

Hum Psychopharmacol. 2010 Mar;25(2):95-102. doi: 10.1002/hup.1094. Review.

PMID:
20196187
41.

Review: clinically important differences between antidepressants.

McAllister-Williams RH.

Evid Based Ment Health. 2009 Nov;12(4):107. doi: 10.1136/ebmh.12.4.107. No abstract available.

PMID:
19854769
42.

Commentary on STAR*D: a summary and UK perspective.

McAllister-Williams R.

J Psychopharmacol. 2009 Aug;23(6):615-7; discussion 622-4. doi: 10.1177/0269881109104889. Epub 2009 Apr 7. No abstract available.

PMID:
19351797
43.

Effects of antidepressant drugs on electroencephalography alpha power: importance of study duration.

Wiśniewski GS, McAllister-Williams RH, Jakitowicz J, Nowicki Z, Majkowicz M, Trzebiatowska IA.

Biol Psychiatry. 2008 Nov 15;64(10):e5-6; author reply e7. doi: 10.1016/j.biopsych.2008.05.036. Epub 2008 Sep 18. No abstract available.

PMID:
18801473
44.

Do antidepressants work? A commentary on "Initial severity and antidepressant benefits: a meta-analysis of data submitted to the Food and Drug Administration" by Kirsch et al.

McAllister-Williams RH.

Evid Based Ment Health. 2008 Aug;11(3):66-8. doi: 10.1136/ebmh.11.3.66. No abstract available.

PMID:
18669671
45.

Misinterpretation of randomized trial evidence: do antidepressants work?

McAllister-Williams RH.

Br J Hosp Med (Lond). 2008 May;69(5):246-7. No abstract available.

PMID:
18557543
46.

Birth weight of infants after maternal exposure to typical and atypical antipsychotics: prospective comparison study.

Newham JJ, Thomas SH, MacRitchie K, McElhatton PR, McAllister-Williams RH.

Br J Psychiatry. 2008 May;192(5):333-7. doi: 10.1192/bjp.bp.107.041541. Erratum in: Br J Psychiatry. 2008 Jun;192(6):477.

PMID:
18450655
47.

Evidence-based guidelines for treating depressive disorders with antidepressants: a revision of the 2000 British Association for Psychopharmacology guidelines.

Anderson IM, Ferrier IN, Baldwin RC, Cowen PJ, Howard L, Lewis G, Matthews K, McAllister-Williams RH, Peveler RC, Scott J, Tylee A.

J Psychopharmacol. 2008 Jun;22(4):343-96. doi: 10.1177/0269881107088441. Epub 2008 Apr 15.

PMID:
18413657
48.

Antidepressants: will new mechanisms of action improve poor outcomes?

Palaniyappan L, McAllister-Williams RH.

Br J Hosp Med (Lond). 2008 Feb;69(2):88-90. Review.

PMID:
18386732
49.

Effects of cortisol on the laterality of the neural correlates of episodic memory.

Alhaj HA, Massey AE, McAllister-Williams RH.

J Psychiatr Res. 2008 Oct;42(12):971-81. doi: 10.1016/j.jpsychires.2007.11.008. Epub 2008 Jan 9.

PMID:
18187154
50.

Graduate mental health worker case management of depression in UK primary care: a pilot study.

McMahon L, Foran KM, Forrest SD, Taylor ML, Ingram G, Rajwal M, Cornwall PL, McAllister-Williams RH.

Br J Gen Pract. 2007 Nov;57(544):880-5.

Supplemental Content

Loading ...
Support Center